DexCom (NASDAQ:DXCM) reported its Q4 earnings results on Thursday, February 8, 2024 at 04:03 PM.
Here’s what investors need to know about the announcement.
Earnings
DexCom beat estimated earnings by 16.28%, reporting an EPS of $0.5 versus an estimate of $0.43.
Revenue was up $219.30 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16 which was followed by a 10.11% increase in the share price the next day.
Here’s a look at DexCom’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.34 | 0.23 | 0.15 | 0.27 |
| EPS Actual | 0.50 | 0.34 | 0.17 | 0.34 |
| Revenue Estimate | 939.24M | 841.62M | 720.74M | 809.65M |
| Revenue Actual | 975.00M | 871.30M | 741.50M | 815.20M |
To track all earnings releases for DexCom visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
